Nabi Biopharmaceuticals (Aloprim) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Buyout/​LBO
  • Financing Rounds
  • 1

Nabi Biopharmaceuticals (Aloprim) General Information

Description

Provider of drugs for the management of patients with leukemia, lymphoma, and solid-tumor malignancies. The company's products help patients who are receiving cancer therapy that cause elevations of serum and urinary uric acid levels.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Acquirer
Primary Office
  • 272 East Deerpath Road
  • Suite 304
  • Lake Forest, IL 60045
  • United States
+1 (847) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Nabi Biopharmaceuticals (Aloprim) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Nabi Biopharmaceuticals (Aloprim)‘s full profile, request access.

Request a free trial